Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus
Clinical trial NCT02916706 · COMPLETED
Trial details
- NCT number
- NCT02916706
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2018-08-14
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.